CRCEF Stage 3 - Request for Applications --- For Researchers

Posted on Friday, October 9, 2020

Dear Colleagues,


Stage 3 of the Canada Research Continuity Emergency Fund (CRCEF) has now been launched, and the purpose of this email is to describe the internal process by which research leads (principal investigators) can apply for funds.This invitation is for principal investigators who hold and manage research funds at the University of Ottawa.  For principal applicants who hold and manage funds at one of the research institutes, please contact your respective research office for more information.

1. CRCEF Program

Stage 3 provides support for extraordinary incremental costs associated with maintaining essential research-related commitments during the COVID-19 pandemic, and then ramping-up to full research activities as physical distancing measures are eased and research activities can resume.  (Eligible expenses are identified below). The University’s notional allocation of this national program is $2,690,430.33 (this does not include the affiliated institutions). Please note that we are able to request additional funds beyond this, if we have the proper justification.

Only direct costs of research are eligible.  Stage 3 funding will be awarded to support direct costs associated with maintenance and ramp-up of research activities. Applicants must justify the need for the funds based on actual costs that have been incurred or costs that will be incurred between March 15 and November 15, 2020. (Please note that in order to meet this eligibility period any new transactions must be incurred by October 21st.)

2. Internal Application Process

As per the Program guidelines, the University is implementing an open and transparent process for the internal allocation of Stage 3 funds to researchers which invites applications from research leads (principal investigators and scientific directors of research platforms).

You are invited to request these funds, following the instructions in the attached template which contains instructions.  When completed, please forward it to your Faculty CAO by October 21 or another date specified by your faculty, for validation and then forward on to RMS.  Please note: all requests must be received by RMS by noon on October 27.

Please note that the minimum amount that can be requested is $250 per transaction.  Eligible expenses are listed at the end of this email as well as in the template.

A central committee will review all requests and assign priorities based on assessment criteria. This information will be compiled into the institutional application which will be sent to the Program on November 9.

If you have any questions, please consult your Faculty CAO, Research Finance (France Boucher:, or RMS (Vivian Liu:

Thank you for your collaboration.


Eligible Expenses

Eligible expenses include costs associated with the following categories:

a) Maintenance costs:

  • Costs incurred within the eligible period and associated with maintaining essential research-related activities during the pandemic that are exceptional and incremental to those already covered by existing sources of funds, funded at up to 75%. This includes:
    • animal and specimen care through the crisis period;
    • maintenance of equipment, software, cohorts, datasets, including warranties, licenses and service contracts;
    • technological equipment for remote access to maintain assets; and
    • safety equipment for personnel dedicated to maintenance.


b) Ramp-up costs:

  • Costs incurred within the eligible period and associated with full ramp-up of research activities, as physical distancing measures are eased and research activities can resume. Only costs that are exceptional and incremental to those already covered by existing sources of funds will be supported, at up to 75%. Eligible expenses include those incurred at the project level and associated with:
    • re-organizing the research environment and activities;
    • additional costs to bring the research back to its pre-pandemic level, including experiments or related to the restart of collections and datasets (e.g., population-based, environmental);
    • user fees charged by shared platforms to researchers to restart research activities (e.g., animal- care facilities, digital labs);
    • re-scheduling and restarting human and clinical trials;
    • exceptional costs to access special facilities, shared platforms and resources, knowledge transfer meetings and workshops;
    • restarting, reassembling and safety checks of equipment and facilities;
    • reacquiring lost and donated laboratory and field supplies and equipment, reagents, perishable materials, laboratory animal and other living specimens; and
    • personal protective equipment and related items for research personnel.


For more information:



Back to top